List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 397 studies with search of: Lamivudine OR Epivir[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz;   Drug: Lamivudine;   Drug: Stavudine
2 Active, not recruiting Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Condition: HIV Infection
Interventions: Drug: ABC/3TC + ATV/r x 36wks followed by ABC/3TC + ATV x 48wks;   Drug: ABC/3TC + ATV/r x 36wks followed by ABC/3TC + ATV/r x 48wks
3 Active, not recruiting Study of Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.
Condition: HIV Infections
Interventions: Drug: Viread (tenofovir disoproxil fumarate);   Drug: Sustiva (Efavirenz);   Drug: Epivir (Lamivudine);   Drug: Zerit (Stavudine)
4 Completed Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Delavirdine mesylate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine
5 Completed A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
Condition: HIV Infection
Interventions: Drug: abacavir/lamivudine;   Drug: abacavir;   Drug: lamivudine
6 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Condition: HIV Infection
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
7 Recruiting Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding
Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: Lamivudine (3TC)
8 Withdrawn Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
Condition: HIV Infections
Interventions: Biological: Influenza Virus Vaccine;   Biological: Pneumococcal Vaccine, Polyvalent (23-valent);   Drug: Lamivudine
9 Completed The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Lamivudine;   Drug: Zidovudine
10 Active, not recruiting A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Nelfinavir mesylate;   Drug: Lamivudine;   Drug: Zidovudine
11 Completed A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine/Zidovudine;   Drug: Abacavir sulfate
12 Completed The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Lamivudine;   Drug: Zidovudine
13 Completed A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine;   Drug: Zidovudine
14 Terminated A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Saquinavir;   Drug: Delavirdine mesylate
15 Completed 3TC (Lamivudine; GR109714X) Open-Label Program
Condition: HIV Infections
Interventions: Drug: Lamivudine;   Drug: Zidovudine
16 Active, not recruiting A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine
17 Recruiting Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Condition: HIV Infections
Interventions: Drug: GPO-Vir Z30 tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Zidovudine
18 Completed Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
Condition: HIV Infections
Interventions: Drug: Lamivudine, nevirapine, and stavudine fixed-dose tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Stavudine
19 Completed A Study of Two Anti-HIV Drug Combinations
Condition: HIV Infections
Interventions: Drug: Lamivudine/Zidovudine;   Drug: Lamivudine;   Drug: Zidovudine
20 Completed Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination
Condition: HIV Infections
Interventions: Drug: Emtricitabine;   Drug: Lamivudine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services